Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Epstein-Barr Virus Infections × Hydroxyurea × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 4 Squamous Cell Carcinoma of Head and Neck 3 Polycythemia Vera 2 Meningioma 2 Treatment-Refractory Solid Tumors 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 HPV-Negative Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Bone Marrow Neoplasms 1 Bites and Stings 1

Interventions

Valganciclovir 3 Cisplatin 3 Vincristine 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Matrix-M 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 pomalidomide 1 dehydroftorafur 1 brincidofovir 1 Watchful Waiting 1 Valacyclovir 1 Tomography, X-Ray Computed 1 Tenofovir 1 Tegafur 1 Taxes 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Interferons 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡